Fermentation method for producing epothilone B by sorangium cellulosum and fermentation medium
Patent Information
- Authority / Receiving Office
- CN · China
- Current Assignee / Owner
- SHANGHAI INST OF PHARMA IND
- Publication Date
- 2010-10-06
- Estimated Expiration
- Not applicable · inactive patent
Smart Images
Figure 1 Figure 2
Abstract
Description
technical field
[0001] The invention relates to a fermentation method and a fermentation medium for producing epothilone B by S. cellulosus. Background technique
[0002] Epothilone B, as a secondary metabolite of the myxobacterium S. cellulosus, is a new type of anti-tumor active substance with ultra-stable microtubules. The mechanism of action of epothilone B is the same as that of paclitaxel, but it is superior to paclitaxel in terms of anti-tumor spectrum, anti-tumor activity, safety, water solubility and synthesis method. It is a new type of anti-tumor drug with broad prospects.
[0003] For the large-scale production of epothilone, biological fermentation is an ideal way. Epothilone B is generally produced by fermentation of the myxobacterium Sorangium cellulosum 90. It is reported in patent WO93 / 10121 that a low-yield epothilone B can be produced by cultivating Sonocystis cellulosus strains in a medium containing carbon sources, nitrogen sources and inorganic salts,...